Tonix Pharmaceuticals Holding Corporation (TNXP) 뉴스

UPDATE - I just looked again and I was cashed out ! And of course I LOST more money ! I got 1/5 of what I put into this piece of shit. I will never again buy stocks under $1.00 - DONE !

Because all they do is play this game. Share price drops = R/S = Dilution = drop = R/S = Dilution = drop = R/S, etc. on to infinity !

Tonix will rinse and repeat the game over and over and over.

No delisting, just FRAUD ! I had my hard earned money STOLEN by their transfer agent. You have been warned !

no delisting!
Maybe in the future they will have to wait to do other reverse splits... who knows, maybe there won't even be any need!

On February 20, 2025, Tonix Pharmaceuticals Holding Corp. (the “Company”) received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of 10 consecutive business days, the Company’s stock had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the NASDAQ Capital Market, as set forth in NASDAQ Listing Rule 5550(a)(2), and that the matter is now closed.

Forward- Looking Statements

This Current Report on Form 8-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and Private Securities Litigation Reform Act, as amended, including those relating to the performance, and continued listing, of the Company’s common stock on the Nasdaq Capital Market, the Company’s product development, clinical trials, clinical and regulatory timelines, market opportunity, competitive position, possible or assumed future results of operations, business strategies, potential growth opportunities and other statement that are predictive in nature. These forward-looking statements are based on current expectations, estimates, forecasts and projections about the industry and markets in which we operate and management’s current beliefs and assumptions.

You’re right about the market being overvalued, holding up by the top 10 of the S&P 500, as well as the Nasdaq 100.
Many of the stocks are around 50% down & more from their year highs.
The big dump this morning maybe bought, as has been the case on prior similar days.
How much longer this strategy will work!
The dumb money has contributed to it, spoiled by 3rd year bull run!
A correction is near.
I am betting on it, by the next Fed’s meeting, earlier is most likely.
Put Options are expensive.
Out of the Money Long Put Spread is a way to make some money.
Don’t be too greedy!
As for tnxp, not sure what the path will be, by then. Still on the sideline.

Nasty day in the market. Maybe the chatter that the market
will be taken down is real (its long overdue for it to happen, way
too many overvalued stocks and other 'things' created just so
there is a place to put all the money floating around that needs to be
'invested' (LOL)

But that said, today marks a breakdown in my sentiment indicator post
todays open. First time in some time that its signaling that 'big' buy orders
aren't dominating the bigger sell side orders.
And it might be because of the overall market hit taking place. But as its
been clear for a while now, the hedge funds/shorts have been at work.
Taking no prisoners. And given how much one side of the poltical spectrum
hates someone, and is looking to blame this someone for a crashing economy?
Look for the market carnage to pick up..

Especially if the fed gets involved..

And Aug is a long ways away isn't it.. (mercy)

Be nice when this one can announce they are no longer under the
threat of being de-listed..

VStock Transfer is a criminal outfit. Read the reviews on google. And Tonix knows it. So that means they are too.

VStock Transfer
2.1 14 Google reviews
Stock broker in Woodmere, New York

When is the next reverse split scheduled? May as well schedule it now. No since in pretending

They are not trying to manage anything but collect salary money by selling shares. I knew that was apparent when they announced the addition of the marketing manager when they have nothing to market

UPDATE - I spoke to my brokerage and the stock transfer company for this fraud. Brokerage said this has never happened before that they know of. Never happened to me either. I am getting NOTHING ! No shares, and no cash out. They STOLE my money ! How is that bullsheet? And the transfer company VStock ??? They hung up on me. You people who own this stock are in grave danger. But a crime has been committed and I am warning you. Oh and I live near VStock so I could drive there easily. Not worth the gas money. You have all been conned who own this stock.

Timber do you know anything about this? Apparently clowns on this board are little babies and cannot answer simple questions I asked in previous post. It's like Romper Room again.

There is no bottom! Tonix will get below a buck again. Their management are grossly incompetent
.

Did you get you shares? Is Grafiti Holdings connected to this one? Because I had 20 shares of TNXP before R/S and I see something called "cash in lieu of shares" for $0.11 !!!! Did I just lose my money again ? WTF?

Still waiting.
New all time Low.
Waiting on 2 days of higher high & higher lows, to begin thinking of a bottom formed!

Short volume highest in 1 week, 407,532 shares, as of yesterday’s close.

got a lot more 'daring' on the open the shorts did...

hmmm wonder where they are getting the shares to short with..

if the shorts are the ones selling this morn to try and push it down, they aren't very energetic about it with 3000 share 'minutes'..

Course, in the vacuum of demand for the shares, it doesn't take much 'risk' to TRY now does it.

EOD tomorrow, February 19th will be the 10th day, trading above $1
Seriously, you count a return to $12 as a good spot!
On pre RS that represents 0.12, which was near an all time low.
Tnxp is setting all time lows, recently.

Don't have a 'clean' buy signal yet, and this may dip some more
before I do. But like the price relative to a conservative target price of
based on the known share count, of around $80-85...

So liking what the chart momentum indicator I use is showing, like the
potential, and yes, know that with 6 months to go, a lot could happen.

But at some point, its LIKELY to meet the listing reqts, and that threat could
go away. An announcement to that effect could be nice (what are they now,
7 days out of the 10 needed?)...

And I suspect that at some point down the road, they will do a forward split to 'make the share' more
affordable and also increase the float to help reduce the volatility and make them available to more folks.

So added 'some' more today, despite my intention to wait for my buy signal to close. But the drop today,
would mean an 7%+ a little return back to $12.. Nice little GIFT IF it does see $12 again..

maybe this stock is going the same way as Mullen 😪

10932 thru 10935 deleted.
Out for today.
Good luck to longs.

I think I may have made a serious mistake.
I will look into it later. Meanwhile,
I tried to delete 10932 thru 10935, but I don’t know how.
I sent a request to Tech Support.
Sorry, if I have misled anyone.
It wasn’t my intent.

Doubt the float is 5.9 Mil either.

I would be shocked if they didn't drop a
couple of million shares post the r/split for
cash.

And looks like in a vacuum of 'news', $11 isn't going
to hold...

Helps explain the big r/split doesn't it. Be hell if they did
a r/split and the share price was dropped sub a $ before they
'met' the listing reqt..

From a chart standpoint? Still seeing the sentiment holding
for the shares, ie, someone is absorbing the shares being dropped.

Getting ready for an 'add' myself.. and liking the opportunity..
cause i am focused on where it could be at come Aug...

Looks like the name mentioned is simply reporting that he was just granted
26 stock options effective the 27th of Feb.

This does not say he is going to 'exercise' them, and what he is reporting is
that for him to exercise the one from 2018, that he will have to pay six figures
to get ONE share (reverse splits wiped out the option grants didn't they)

Not sure what you are seeing unless I am missing something.

But again, this is just this individual REPORTING the stock options he
has been granted over the years that he HASN"T exercised yet. And given the
price he will have to pay for the one share? Doubt he ever does for any of them
except maybe the last couple.

Link to Form 3 on SEC site
https://www.sec.gov/Archives/edgar/data/1430306/000199937125001700/xslF345X02/fogarty-form3.xml

Taking a small position is more likely, when technicals are not fully aligned (to one’s standards, which I did for FOMO.
However, a more substantial position warrants patience.
If it results in averaging up a little, then be it.
If it has not bottomed yet, then it’ll be averaging down to 2x the current position in the near future!.
@ some point, time will come to double down again.
It isn’t all in @ once.
5k shares entry, waiting to double, then hoping to double down again to 20K.
This is not a day trade or a short term strategy.
No one knows where the bottom is.
Look at the historical chart on TNXP!
But investors are expecting 2025 to be different!
It will all depend on news around end of Q3 2025.
6 month from now.
Hopefully Options will become available before then, but even far out of the money options will not be cheap!

The reverse split absolutely killed the momentum. Terrible timing. These guys are idiots.

Took an all day charting course many years ago put on by Investors Business Daily.
Learned a lot, but the one thing that bothered me about their approach was, while they
selected 'quality' companies based on what they had to see to consider trading a companys stock.

Their approach was to wait until the stock had come up off its lows and clear the price point that was,
when the consolidation phase commenced. The interesting part was, some pullbacks are good for 10-20%
from this price. And as I watched/studied, I was left to ask, why would you 'wait' if you could capture some of this
pullback. And if the breakout failed to clear that price point, you could sell out with something vs nothing at all..

So I did something to see if I could capture some of this 'lift off'..

So do I wait for a peak to confirm? And a perfect 'low' to buy off of? Naw, Burt Baruch said it best, 'made my fortune by
not buying at the lows, nor selling at the peak'.. and it works.. question is, does your charting approach get ya 'close' to
at least the lows.. agree, the peaks are much harder to see coming..

Short volume @ 98.6k, only 1.76% of float!
Keeps getting lower.
Is it because it’s getting expensive to borrow shares & harder to borrow due to very much lower outstanding shares!
Or Change in sentiment (as wolf7 wrote!), Risk/Reward not in favor of shorts!
It will soon become clear.
It’s getting interesting, for anyone who likes Suspense.

It wasn’t my intent to disagree with you.
I am looking for more.
Red to yellow, waiting on green light
It isn’t about buying at the bottom, nor selling at the top, which is impossible, not a good strategy.
I picked up some, to see it drop 30% more.
Short volume @ 98.6k
Keeps getting lower

HomerRomer

there is always the issue of, was the TRIAL and its design
robust enough to be accepted by the FDA.

I had ATNM that I had followed for several years, traded it
along the way as it gave. They passed their PH 3 with flying
colors and their development REALLY HELPED people dealing
with a type of cancer. REALLY HELPED.

They went to the fda, who obviously was consulted in the design
of the trial, the endpoints, with an NDA.

The only good thing was, I had not loaded up on shares because
there was a delay in the fdas acceptance of their submission (I had a
couple of thousand shares, but not as many as I planned to have for the
PDUFA date).

Turns out, the fda rejected the submission because the fda decided the
acceptance criteria the PH 3 met, wasn't good enough. Told ATNM
they had to rerun the trial and use new acceptance criteria.

My first reaction was, who in the hell wanted people to die, that instead of
saying, we will approve you cause you aren't hurting people, you are actually
helping people, but we want you to run a PH 4 with this as acceptance criteria.

So I am at the point, no matter how good things 'appear to be', don't rule out
a gov''t body surprising you at the last minute (for reasons)

pretty apparent we have differences in how we
view things. Cause I don't care about new highs, new lows
as part of the bottoming formation.

Cause that/s not the way my system works.

I already said, something changed on that big volume day
7 Feb.. said the sentiment 'shifted'..

and the chart is looking prettier since then..

and by the way, its been 12/13 days since the correction started.
2 weeks of the 5 weeks minimum I NORMALLY like to see for a good
bottoming action. But that big volume day on the 7th?? That really helped
to flush out a lot of folks.

next week will be interesting. IMO

THIS IS WHAT IT IS ALL GOING TO COME DOWN TO:
You said:
Did Tonix Pharmaceuticals TNX-102 SL for Fibromyalgia meet primary endpoints?
ChatGPT said:
Yes, Tonix Pharmaceuticals' TNX-102 SL for fibromyalgia met its primary endpoints in two Phase 3 clinical trials:

Phase 3 RELIEF Study (Completed December 2020):

Primary Endpoint: Significant reduction in daily pain compared to placebo (p=0.010).
Key Secondary Endpoints: Improved sleep quality, reduced fatigue, and enhanced global symptomatic and functional recovery.
Safety Profile: Generally well-tolerated with adverse events comparable to prior studies.
SEC.GOV
Phase 3 RESILIENT Study (Completed December 2023):

Primary Endpoint: Significant reduction in daily pain compared to placebo (p=0.00005).
Key Secondary Endpoints: Statistically significant improvements in sleep quality, reduced fatigue, and better overall fibromyalgia symptoms and function.
Safety Profile: Well-tolerated with no new safety signals observed.
IR.TONIXPHARMA.COM
These results support the efficacy and safety of TNX-102 SL for fibromyalgia management.


If a drug in the Fast Track program has no safety concerns and has successfully met both primary endpoints in its clinical trials, the likelihood of FDA approval increases significantly. Here's why:

Meeting Primary Endpoints:

Achieving both primary endpoints is a crucial factor. Primary endpoints are the main goals set out in the clinical trial (e.g., efficacy, specific measures of health improvements). If both of these are met, it suggests the drug is effective for its intended use, which is a key requirement for approval.
No Safety Concerns:

The absence of safety issues is another major factor that plays in favor of approval. The FDA places a high emphasis on the safety profile of a drug, and if no serious adverse effects are observed, the likelihood of approval is much higher.
Fast Track Advantages:

Since the drug has already met its endpoints and has no safety concerns, it’s possible that the Fast Track program could lead to an expedited review process and an earlier approval decision. The FDA's additional guidance and quicker responses during Fast Track may help the drug maker address any remaining issues efficiently, allowing for a smoother approval process.
Probability of Approval:

While there’s still a final evaluation of the overall risk/benefit profile of the drug, having demonstrated efficacy and a solid safety profile puts the drug in a very favorable position.
Historically, drugs that have met both primary endpoints and shown no major safety concerns have a very high chance of approval. Approval odds can rise to 80-90% or higher in such cases, as long as there are no other issues (like manufacturing concerns or inadequate post-market surveillance plans).
In summary, if the drug in question has met both primary endpoints and has no safety concerns, it's in a strong position to receive FDA approval, especially when fast-tracked. While approval isn’t guaranteed, the probability is much higher compared to drugs that haven’t reached these milestones.


In October 2024, Tonix submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TNX-102 SL. The FDA accepted the NDA in December 2024, with a decision on approval expected in 2025.
GLOBENEWSWIRE.COM

If approved, TNX-102 SL would be the first new drug treatment option for fibromyalgia patients in 15 years.

90%+ chance of approval within the next 6 months will result in MASSIVE stock appreciation! Huge market for the drug also. That all makes this stock very undervalued at a $65 million market cap!!

New low on the 6th @ 10.83
Show me 2 days of higher high & higher lows post split low, to begin thinking of a bottom formed!

Might be time to send their IR a WTHell email asking about it..

At the same time, the chart is 'improving' from the standpoint of hinting
the bottom may be firming up (say MAYBE, cause it won't take much to hit
it and blow the trend into disarray).

But the chart is showing a slow change in momentum to the point its hinting
towards demand IS overriding selling?? Waiting for the chart to 'confirm' the
change.. Tempted to add some more this morn..

I had 20 shares sent out and STILL have not received my 1 share or any cash out ! WTF? They sent the shares out 2/5/25

1 billion shares prior to the split were authorized.
They spent/used 500 million of the 1 billion, that’s how the outstanding shares rose to 559 shares in Jan 25, right before the RS (which explains the action on tnxp).
This part is clear as daylight.
Then think about what you’re implying of the remaining number of shares. It implies 100,000,000,000 (100 billion on pre-split basis, since you’re keeping the same 1 billion basis.
The wording you highlighted in Red from the filing, it’s a fact, but subject to the RV.
Ask you broker, assuming the person you get is knowledgeable!
Ask your AI, like MSFT CoPilot

OK, we are going to disagree on the '#
of authorized shares' to sell cause normally
I would agree with you that the ratio would be
applied. Have to see what they say in their next
SEC filing that covers it.

Obviously, if I thought there were 1 Billion shares
'authorized', subtracting 5.6 Million in the float would
give around 994 Million give or take a few...

No, far from it.
1st, about 500 million shares out of the 1 billion shares were already exercised, I mean they were part of the outstanding shares when the RS took effect.
2nd, as far as the remaining 500 million shares, the same RS apply to them, since the 1 billion shares were authorized prior to the split, meaning at most another 5 million share can be released, added to outstanding shares.
You’re right, what was authorized can’t be changed, unless another filing is issued to do so.
The 1 billion shares wording can’t be changed, but the remaining shares are subject to the RS.
How did you come up with 994 million shares, when 500 million shares were subject to the RS, they were outstanding prior to the RS.

Effect of the R/split on authorized shares:

Pretty sure what this is saying is, the number of AUTHORIZED will remain
at 1 Billion, while the outstanding gets the 1-100 reduction. No?

Meaning they can now sell up to 994 Million shares at the ATM or offer
them as pension, or....
To close, I agree with you, with regard to the 1-100 should have been applied to the
authorized, but thats not what I am reading and why I made the comment in the
first place..

From page 3 of the filing on 2/3/2025:

Capitalization. The number of authorized shares of Common Stock was and will remain
at 1,000,000,000 following the Reverse Stock Split.

As of January 31, 2025 there were 559,044,486 shares of Common Stock outstanding.
As a result of the Reverse Stock Split, there will be approximately 5,590,445 shares of Common Stock
outstanding (subject to adjustment due to the effect of rounding fractional shares into whole shares).
The Reverse Stock Split will not have any effect on number of authorized
shares of Common Stock or the stated par value of the Common Stock.

Tnxp is up 0.67%, She is rockin and rollin!

After Tonix Pharmaceuticals executed the 1-for-100 reverse stock split, the remaining authorized shares are still authorized in the same total amount (1 billion shares). However, they are now represented in a 1-to-100 ratio compared to the pre-split shares.
This means that those approximately 500 million pre-split remaining shares are now represented as 5 million post-split shares.
So, without a new future filing for more share, tnxp maximum number of outstanding shares can rise to approximately double the current post split outstanding shares.

My take on the 'authorized' shares vs share count:
=its an ATM to be used as they determine 'necessary'
=it allows for usage of shares as needed for 'compensation' purposes

Agree, 5.6 Million shares at the moment, that heavy sale to get to this number
is why I cut my target price to a 1/3rd of what I originally had (now around $80/sh vs $300)

And I suspect if they had their act together, they unleashed some more with the share price at $20.
They would have been foolish not to.

So no idea where the share count is at now, but wouldn't be surprised if my target price is now down to $70
and I don't know it.

The 'good news' is, given my cost basis, I will do quite well if it reaches $70. But yeah, have made my last ad
till I see the share price starting to roll up.

Note: TNXP and another one is the first time I have seen a r/split NOT reduce the shares authorized number as well.
That is a bit disconcerting.. And not used to seeing numbers like 400,000,000 million AUTHORIZED shares either.
Tho do understand, the companys interest is in their own survival, and ours is to hope to ride their efforts to some success.
So anyone believing a company is putting shareholder interests into consideration, needs to understand, its the BIG
shareholders they are careful not antagonize, not us retailers..

Shorts & everyone else,
Not looking for speculative answers/opinions,
Looking for fact supported response.
My Plan to buy more shares is on hold for now, why?
Last year Tonix filed notice to issue up to 1 billion more shares.
It had about 24 million shares outstanding in 2024.
Increased to 186.6 million shares in 2024.
In January 2025 the number of outstanding shares increased to 559 million shares.
Then came the 1 - to - 100 RS, (559/100=5.59 million shares outstanding)
The Q is why didn’t Tonix issue the authorized 1 billion shares?
Does this mean that Tonix has the ability to issue the remaining number of shares at Will, to raise cash!
Or was most of the remaining shares kept for top employees (executive level) options Plan!
If the former proven to be true, Tonix can flood the market with about 500 million shares!
Looking for factual input.

Again, less than yesterday’s lowest.
Short volume is the lowest I’ve seen in months!
5.8% of outstanding shares.

Volume decreasing since last Fridays massive number.. might
be the start of that phase between 'capitulation' and waiting for demand
to develop.
Got to flush out the last of the 'unsure', yet unfortunately, not
enough demand to stop the shorts from trying IF they still are
thinking about it.

Tonix is headed into the single digits and below. Then it will be time for another R/S. Good luck!

Good day to try to take another run at dropping it.

Inflation hot, market weak. Pretty good volume (approx 34,000 shs) right after
the open.. to drop it...

Guessing post the split, likely not your 'average' retailer??

Short volume is the lowest I’ve seen in months!

Yep, TNXPs chart 'trends' were wrecked with the r/split news, the
driving down of the share price.

Now the chart is going thru a hard reset as shareholders make their
choices on what they do next. And its going to take 'some' (undefined
cause shakeouts can be quick or long) time to put in a bottom and
the company to reaffirm why folks should want their shares going
forward.

But like the chart this morn. The sentiment indicator I use is showing
bigger 'buy' orders are dominating big sell side orders. IE, whats that saying,
when a stocks price crashes, its the smaller retailers that do the selling at the lows
while the smart money does the scooping up of the cheap offerings.

And again, this is with the biosector under pressure (IBB, XBI, LABU)